Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

NCT03564470 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Leukemia, Acute
Leukemia, Lymphoblastic
Leukemia, B-cell

Interventions

DRUG: Chidamide
DRUG: Dasatinib

Sponsor

Nanfang Hospital, Southern Medical University